{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:23:06Z","timestamp":1788258186943,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41391-021-00390-9","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T17:03:26Z","timestamp":1621357406000},"page":"1189-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Oncological and functional outcome after partial prostate HIFU ablation with Focal-One\u00ae: a prospective single-center study"],"prefix":"10.1038","volume":"24","author":[{"given":"Marco","family":"Dellabella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Branchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-4159","authenticated-orcid":false,"given":"Mirko","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gasparri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redi","family":"Claudini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-9190","authenticated-orcid":false,"given":"Daniele","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M. et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618\u201329.","journal-title":"Eur Urol"},{"key":"390_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl J Med. 2016;375:1415\u201324.","journal-title":"N. Engl J Med"},{"key":"390_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl J Med. 2016;375:1425\u201337.","journal-title":"N. Engl J Med"},{"key":"390_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE, Lepor H, Catto J. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71:17\u201334.","journal-title":"Eur Urol"},{"key":"390_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","volume":"361","author":"HU Ahmed","year":"2009","unstructured":"Ahmed HU. The index lesion and the origin of prostate cancer. N. Engl J Med. 2009;361:1704\u20136.","journal-title":"N. Engl J Med"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nm.1944","volume":"15","author":"W Liu","year":"2009","unstructured":"Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med. 2009;15:559\u201365.","journal-title":"Nat Med"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.humpath.2011.06.018","volume":"43","author":"CC Guo","year":"2012","unstructured":"Guo CC, Wang Y, Xiao L, Troncoso P, Czerniak BA. The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers. Hum Pathol. 2012;43:644\u20139.","journal-title":"Hum Pathol"},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41391-020-0206-6","volume":"23","author":"MJ Connor","year":"2020","unstructured":"Connor MJ, Gorin MA, Ahmed HU, Nigam R. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI. Prostate Cancer Prostatic Dis. 2020;23:232\u201343.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"390_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40349-014-0022-3","volume":"3","author":"A Gelet","year":"2015","unstructured":"Gelet A, Crouzet S, Rouviere O, Bratan F, Chapelon J-Y. Focal treatment of prostate cancer using Focal One device: pilot study results. J Ther Ultrasound. 2015;3:1\u20132.","journal-title":"J Ther Ultrasound"},{"key":"390_CR10","doi-asserted-by":"crossref","unstructured":"Capogrosso P, Barret E. High-intensity focused ultrasound. In: Polascik TJ, editor. Imaging and focal therapy of early prostate cancer. Springer; 2017. p 309\u2013323 (Springer, 2017).","DOI":"10.1007\/978-3-319-49911-6_24"},{"key":"390_CR11","first-page":"825","volume":"72","author":"OR Claros","year":"2019","unstructured":"Claros OR, Tourinho-Barbosa RR, Carneiro A, Collura-Merlier S, Macek P, Lanz C. et al. HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound. Arch Esp Urol. 2019;72:825\u201330.","journal-title":"Arch Esp Urol"},{"key":"390_CR12","first-page":"401.e1","volume":"36","author":"J von Hardenberg","year":"2018","unstructured":"von Hardenberg J, Westhoff N, Baumunk D, Hausmann D, Martini T, Marx A, et al. Prostate cancer treatment by the latest focal HIFU device with MRI\/TRUS-fusion control biopsies: a prospective evaluation. Urol Oncol Semin Orig Investig. 2018;36:401.e1\u2013401.e9.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.acuro.2016.04.016","volume":"40","author":"JI Perez-Reggeti","year":"2016","unstructured":"Perez-Reggeti JI, Sanchez-Salas R, Sivaraman A, Linares Espinos E, de Gracia-Nieto AE, Barret E. et al. High intensity focused ultrasound with Focal-One\u00ae device: Prostate-specific antigen impact and morbidity evaluation during the initial experience. Actas Urol Esp. 2016;40:608\u201314.","journal-title":"Actas Urol Esp"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/end.2018.0809","volume":"33","author":"A Bakavicius","year":"2019","unstructured":"Bakavicius A, Sanchez-Salas R, Muttin F, Sivaraman A, Dell\u2019Oglio P, Barret E. et al. Comprehensive evaluation of focal therapy complications in prostate cancer: a standardized methodology. J Endourol. 2019;33:509\u201315.","journal-title":"J Endourol"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso A, Epstein JI. Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology. 2019;74:135\u201345.","journal-title":"Histopathology"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","volume":"69","author":"JO Barentsz","year":"2016","unstructured":"Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F. et al. Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol. 2016;69:41\u201349.","journal-title":"Eur Urol"},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.clgc.2020.02.006","volume":"18","author":"S Cecchini","year":"2020","unstructured":"Cecchini S, Castellani D, Fabbietti P, Mazzucchelli R, Montironi R, Cecarini M, et al. Combination of multiparametric magnetic resonance imaging with elastic-fusion biopsy has a high sensitivity in detecting clinically significant prostate cancer in daily practice. Clin Genitourin Cancer. 2020;18:e501\u2013e509.","journal-title":"Clin Genitourin Cancer"},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.urology.2017.11.037","volume":"113","author":"M Dellabella","year":"2018","unstructured":"Dellabella M, Castellani D. Anatomical control of adenoma technique: an accurate surgical approach to thulium laser enucleation of the prostate. Urology. 2018;113:252.","journal-title":"Urology"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2016.07.004","volume":"51","author":"EJ Bass","year":"2016","unstructured":"Bass EJ, Ahmed HU. Focal therapy in prostate cancer: a review of seven common controversies. Cancer Treat Rev 2016;51:27\u201334.","journal-title":"Cancer Treat Rev"},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4111\/icu.2019.60.4.312","volume":"60","author":"D Castellani","year":"2019","unstructured":"Castellani D, Branchi A, Claudini R, Gasparri L, Pierangeli T, Ravasi E. et al. A structured framework for optimizing high-intensity focused ultrasound ablative treatment in localized prostate cancer. Investig Clin Urol. 2019;60:312\u20138.","journal-title":"Investig Clin Urol"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","volume":"59","author":"L Dickinson","year":"2011","unstructured":"Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59:477\u201394.","journal-title":"Eur Urol"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00345-016-1782-x","volume":"34","author":"AW Postema","year":"2016","unstructured":"Postema AW, De Reijke TM, Ukimura O, Van den Bos W, Azzouzi AR, Barret E. et al. Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project. World J Urol. 2016;34:1373\u201382.","journal-title":"World J Urol"},{"key":"390_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00345-014-1475-2","volume":"33","author":"BG Muller","year":"2015","unstructured":"Muller BG, van den Bos W, Brausi M, F\u00fctterer JJ, Ghai S, Pinto PA. et al. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J Urol. 2015;33:1503\u20139.","journal-title":"World J Urol"},{"key":"390_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1464-410X.2009.08518.x","volume":"104","author":"A Blana","year":"2009","unstructured":"Blana A, Brown SCW, Chaussy C, Conti GN, Eastham JA, Ganzer R, et al. High-intensity focused ultrasound for prostate cancer: Comparative definitions of biochemical failure. BJU Int. 2009;104:1058\u201362.","journal-title":"BJU Int"},{"key":"390_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","volume":"67","author":"IA Donaldson","year":"2015","unstructured":"Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S. et al. Focal therapy: patients, interventions, and outcomes\u2014a report from a consensus meeting. Eur Urol. 2015;67:771\u20137.","journal-title":"Eur Urol"},{"key":"390_CR26","doi-asserted-by":"publisher","unstructured":"Castellani D. Focal HIFU in localized prostate cancer. Mendeley Data, v1. 2020. https:\/\/doi.org\/10.17632\/rnn78wj7j9.1.","DOI":"10.17632\/rnn78wj7j9.1"},{"key":"390_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","volume":"74","author":"S Guillaumier","year":"2018","unstructured":"Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T. et al. A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer. Eur Urol. 2018;74:422\u20139.","journal-title":"Eur Urol"},{"key":"390_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.eururo.2016.09.039","volume":"71","author":"P Rischmann","year":"2017","unstructured":"Rischmann P, Gelet A, Riche B, Villers A, Pasticier G, Bondil P. et al. Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients. Eur Urol. 2017;71:267\u201373.","journal-title":"Eur Urol"},{"key":"390_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bju.14710","volume":"124","author":"A Stabile","year":"2019","unstructured":"Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, et al. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. BJU Int. 2019;124:431\u201340.","journal-title":"BJU Int"},{"key":"390_CR30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.juro.2013.03.116","volume":"190","author":"S Shoji","year":"2013","unstructured":"Shoji S, Uchida T, Nakamoto M, Kim H, de Castro Abreu AL, Leslie S. et al. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy. J Urol. 2013;190:1224\u201332.","journal-title":"J Urol"},{"key":"390_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5306\/wjco.v2.i1.8","volume":"2","author":"Y-F Zhou","year":"2011","unstructured":"Zhou Y-F. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2011;2:8\u201327.","journal-title":"World J Clin Oncol"},{"key":"390_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/02656739409009351","volume":"10","author":"WC Dewey","year":"1994","unstructured":"Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperth. 1994;10:457\u201383.","journal-title":"Int J Hyperth"},{"key":"390_CR33","doi-asserted-by":"publisher","unstructured":"Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. World J Urol. 2020. https:\/\/doi.org\/10.1007\/s00345-020-03297-7.","DOI":"10.1007\/s00345-020-03297-7"},{"key":"390_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.eururo.2015.12.015","volume":"69","author":"A Sivaraman","year":"2016","unstructured":"Sivaraman A, Barret E. Focal therapy for prostate cancer: an \u2018\u00e0 la Carte\u2019 approach. Eur Urol. 2016;69:973\u20135.","journal-title":"Eur Urol"},{"key":"390_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amsu.2020.05.029","volume":"56","author":"F Ziglioli","year":"2020","unstructured":"Ziglioli F, Baciarello M, Maspero G, Bellini V, Bocchialini T, Cavalieri D. et al. Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review. Ann Med Surg. 2020;56:110\u20135.","journal-title":"Ann Med Surg"},{"key":"390_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22520","volume":"22","author":"FC Hamdy","year":"2018","unstructured":"Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C. et al. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT. Health Technol Assess. 2018;22:1\u201396.","journal-title":"Health Technol Assess"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00390-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:35:20Z","timestamp":1684618520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00390-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1038\/s41391-021-00390-9","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A. Branchi does HIFU tutorship for EDAP-TMS and receives honoraria for his tutorship. M.D., M.D.R., M.P., L.G., R.C., F.C., S.C., and D.C. declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}